Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Intellicell Biosciences Inc Appoints New Chairman


Wednesday, 30 Oct 2013 10:30am EDT 

IntelliCell BioSciences, Inc announced that it has appointed Mr. Michael Herschman to serve as the Chairman of the Board of Directors. 

Company Quote

0.0053
2.0E-4 +3.92%
17 Apr 2014